Studies have suggested that the lymph node yield and lymph node density from selective or elective neck dissections are predictive of patient outcomes and may be used for patient counseling, treatment planning, or quality measurement. Our objective was to systematically review the literature and conduct a meta-analysis of studies that investigated the prognostic significance of lymph node yield and/or lymph node density after neck dissection for patients with head and neck cancer.
Data Sources
The Ovid/Medline, Ovid/Embase, and NLM PubMed databases were systematically searched on January 23, 2017, for articles published between January 1, 1946, and January 23, 2017.
Review Methods
We reviewed English-language original research that included survival analysis of patients undergoing neck dissection for a head and neck malignancy stratified by lymph node yield and/or lymph node density. Study data were extracted by 2 independent researchers (S.C. and M.O.). We utilized the DerSimonian and Laird random effects model to account for heterogeneity of studies.
Results
Our search yielded 350 nonduplicate articles, with 23 studies included in the final synthesis. Pooled results demonstrated that increased lymph node yield was associated with a significant improvement in survival (hazard ratio, 0.833; 95% CI, 0.790-0.879). Additionally, we found that increased lymph node density was associated with poorer survival (hazard ratio, 1.916; 95% CI, 1.637-2.241).
Conclusions
Increased nodal yield portends improved outcomes and may be a valuable quality indicator for neck dissections, while increased lymph node density is associated with diminished survival and may be used for postsurgical counseling and planning for adjuvant therapy.
American Cancer Society. Cancer Facts and Figures 2017. Atlanta, GA: American Cancer Society; 2017.
2.
ArgirisAKaramouzisMVRabenDFerrisRL.Head and neck cancer. Lancet. 2008;371:1695-1709.
3.
CohenEELingenMWVokesEE.The expanding role of systemic therapy in head and neck cancer. J Clin Oncol. 2004;22:1743-1752.
4.
SchwamZGJudsonBL.Improved prognosis for patients with oral cavity squamous cell carcinoma: analysis of the National Cancer Database 1998-2006. Oral Oncol. 2016;52:45-51.
ClaymanGLFrankDK.Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg. 1998;124:348-353.
7.
PitmanKTJohnsonJTMyersEN.Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg. 1997;123:917-922.
8.
AndersenPEWarrenFSpiroJet al. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg. 2002;128:1180-1184.
9.
PellitteriPKRobbinsKTNeumanT.Expanded application of selective neck dissection with regard to nodal status. Head Neck. 1997;19:260-265.
10.
DeutschmannMWChin-LennLAuJet al. Extent of central neck dissection among thyroid cancer surgeons: cross-sectional analysis. Head Neck. 2016;38(suppl 1):E328-E332.
11.
VeeramachaneniNKZooleJBDeckerPAPutnamJBJr.MeyersBF.Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial. Ann Thorac Surg. 2008;86:418-421.
12.
DarlingGEAllenMSDeckerPAet al. Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. Chest. 2011;139:1124-1129.
13.
KuoPMehraSSosaJAet al. Proposing prognostic thresholds for lymph node yield in clinically lymph node-negative and lymph node-positive cancers of the oral cavity. Cancer. 2016;122:3624-3631.
14.
DiviVChenMMNussenbaumBet al. Lymph node count from neck dissection predicts mortality in head and neck cancer. J Clin Oncol. 2016;34:3892-3897.
15.
DiviVHarrisJHarariPMet al. Establishing quality indicators for neck dissection: correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer. 2016;122:3464-3471.
16.
PrabhuRSHanasogeSMaglioccaKRet al. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck. 2015;37:777-782.
17.
ImreAPinarEDincerEet al. Lymph node density in node-positive laryngeal carcinoma: analysis of prognostic value for survival. Otolaryngol Head Neck Surg. 2016;155:797-804.
18.
OngWZhaoRLuiBet al. Prognostic significance of lymph node density in squamous cell carcinoma of the tongue. Head Neck. 2016;38(suppl 1):E859-E866.
19.
EbrahimiAClarkJRZhangWJet al. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck. 2011;33:1245-1251.
20.
GilZCarlsonDLBoyleJOet al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115:5700-5710.
21.
LiaoCTHsuehCLeeLYet al. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol. 2012;48:329-336.
22.
KunzelJMantsopoulosKPsychogiosGet al. Lymph node ratio is of limited value for the decision-making process in the treatment of patients with laryngeal cancer. Eur Arch Otorhinolaryngol. 2015;272:453-461.
23.
Veritas Health Innovation. Covidence systematic review software. http://www.covidence.org/. Accessed January 2017.
24.
OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford, UK: Oxford Centre for Evidence-Based Medicine; 2011.
25.
GauglerJEDuvalSAndersonKAKaneRL.Predicting nursing home admission in the US: a meta-analysis. BMC Geriatr. 2007;7:13.
26.
MarshallDJohnellOWedelH.Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254-1259.
27.
BarthJSchumacherMHerrmann-LingenC.Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802-813.
28.
HodgeVAustinJ.A survey of outlier detection methodologies. Artif Intell Rev. 2004;22:85-126.
29.
ThompsonSGHigginsJ.How should meta-regression analyses be undertaken and interpreted?Stat Med. 2002;21:1559-1573.
30.
HarbordRMHigginsJ.Meta-regression in Stata. Meta. 2008;8:493-519.
31.
DerSimonianRLairdN.Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
32.
MantelNHaenszelW.Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
33.
MoherDLiberatiATetzlaffJAltmanDGPrismaG.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
34.
LemieuxAKedarisettySRajuSOroscoRCoffeyC.Lymph node yield as a predictor of survival in pathologically node negative oral cavity carcinoma. Otolaryngol Head Neck Surg. 2016;154:465-472.
35.
EbrahimiAZhangWJGaoKClarkJR.Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer. 2011;117:2917-2925.
36.
EbrahimiAClarkJRAmitMet al. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study. Ann Surg Oncol. 2014;21:3049-3055.
37.
BottcherADommerichSSanderSet al. Nodal yield of neck dissections and influence on outcome in laryngectomized patients. Eur Arch Otorhinolaryngol. 2016;273:3321-3329.
38.
ChassinMRLoebJMSchmaltzSPWachterRM.Accountability measures—using measurement to promote quality improvement. N Engl J Med. 2010;363:683-688.
39.
BonowROMasoudiFARumsfeldJSet al. ACC/AHA classification of care metrics: performance measures and quality metrics. Circulation. 2008;118:2662.
40.
ChassinMRGalvinRW.The urgent need to improve health care quality: Institute of Medicine National Roundtable on Health Care Quality. JAMA. 1998;280:1000-1005.
41.
AminMBEdgeSB.AJCC Cancer Staging Manual. 8th ed.New York, NY: Springer; 2017.
42.
ChouJFRowDGonenMLiuYHSchragDWeiserMR.Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer. Cancer. 2010;116:2560-2570.
43.
MekenkampLJvan KriekenJHMarijnenCAet al. Lymph node retrieval in rectal cancer is dependent on many factors—the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 2009;33:1547-1553.
44.
ThornCWoodcockNScottNVerbekeCScottSAmbroseN.What factors affect lymph node yield in surgery for rectal cancer?Colorectal Dis. 2004;6:356-361.
45.
MarijnenCANagtegaalIDKlein KranenbargEet al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;19:1976-1984.
46.
WichmannMWMullerCMeyerGet al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg. 2002;137:206-210.
47.
BamboatZMDePeraltaDDursunABergerDLBordeianouL.Factors affecting lymph node yield from patients undergoing colectomy for cancer. Int J Colorectal Dis. 2011;26:1163-1168.
48.
OstadiMAHarnishJLStegienkoSUrbachDR.Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc. 2007;21:2142-2146.
49.
ShrimeMGMaCGullanePJet al. Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31:1129-1136.
50.
ShrimeMGBacharGLeaJet al. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31:1482-1488.
51.
PatelSGAmitMYenTCet al. Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br J Cancer. 2013;109:2087-2095.
52.
HuaYHHuQYPiaoYFTangQFuZF.Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer. Head Neck. 2015;37:111-116.
53.
JooYHChoKJKimSYKimMS.Prognostic significance of lymph node density in patients with hypopharyngeal squamous cell carcinoma. Ann Surg Oncol. 2015;22(suppl 3):S1014-S1019.
54.
SuzukiHMatobaTHanaiNet al. Lymph node ratio predicts survival in hypopharyngeal cancer with positive lymph node metastasis. Eur Arch Otorhinolaryngol. 2016;273:4595-4600.
55.
KunzelJPsychogiosGMantsopoulosKGrundtnerPWaldfahrerFIroH.Lymph node ratio as a predictor of outcome in patients with oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2014;271:1171-1180.
56.
de RidderMMarresCCSmeeleLEet al. A critical evaluation of lymph node ratio in head and neck cancer. Virchows Arch. 2016;469:635-641.
57.
RudraSSpiottoMTWittMEBlairEAStensonKHarafDJ.Lymph node density—prognostic value in head and neck cancer. Head Neck. 2014;36:266-272.
58.
PassoniNMAbdollahFSuardiNet al. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. Urol Oncol. 2014;32:29.e21-e28.
59.
KuJHKangMKimHSJeongCWKwakCKimHH.Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis. BMC Cancer. 2015;15:447.
60.
RobertsTJColevasADHaraWHolsingerFCOakley-GirvanIDiviV.Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Cancer. 2016;122:1388-1397.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
